News & Articles

Chinese Medicine, or Chinese Proprietary Medicine (CPM), holds a significant place in the wellness landscape, particularly in Singapore. However, the use of certain ingredients within these medicines is strictly regulated to ensure safety and effectiveness. It’s essential for manufacturers, practitioners, and consumers to understand which substances are prohibited, the health risks they may pose, and […]

In the ever-evolving healthcare landscape, managing change notification to registered medical devices is critical to maintaining their safety and performance in accordance with Essential Principles Checklist of Standards claims. With regulations becoming stricter, manufacturers and stakeholders need a clear understanding of the necessary procedures involved in handling updates, modifications, and post-registration changes. This article breaks […]

In Singapore’s bustling cosmetic market, the allure of new and innovative products can sometimes distract businesses from the crucial need for regulatory compliance. While consumers eagerly seek the latest beauty trends, many businesses may unknowingly supply un-notified cosmetic products. This oversight not only poses risks to consumer safety but also poses serious consequences for businesses, […]

Brazil pharmaceutical companies offer a diverse and innovative portfolio of products. However, due to geographical distance, most companies focus on developing their market within Brazil and the U.S. There are many compelling reasons for Brazilian companies to consider expanding into Singapore and other ASEAN countries, where they can leverage strategic regulatory advantages and market opportunities […]

In recent times, we’ve received numerous inquiries about the possibility of rebranding complementary health and cosmetic products in Singapore, particularly due to geopolitical factors. Many companies are looking to facilitate export to their home countries, and understanding how to rebrand products as “Made in Singapore” can be a strategic advantage. In this article, we’ll explore […]

China’s primary regulatory authority is the National Medical Products Administration (NMPA). The pharmaceutical landscape continues to evolve globally, with different countries adopting distinct approaches to ensure the safety, quality, and efficacy of medicinal products. China and Singapore are both dynamic markets with growing demand for innovative therapies. However, their regulatory environments differ significantly and can […]